Last reviewed · How we verify
Sustained-Release Desvenlafaxine Hydrochloride
Sustained-Release Desvenlafaxine Hydrochloride is a Small molecule drug developed by Jiangsu Hansoh Pharmaceutical Co., Ltd.. It is currently in Phase 2 development.
At a glance
| Generic name | Sustained-Release Desvenlafaxine Hydrochloride |
|---|---|
| Sponsor | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder (NA)
- Study of Desvenlafaxine in Treating Major Depressive Disorder. (PHASE3)
- A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder (PHASE2, PHASE3)
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sustained-Release Desvenlafaxine Hydrochloride CI brief — competitive landscape report
- Sustained-Release Desvenlafaxine Hydrochloride updates RSS · CI watch RSS
- Jiangsu Hansoh Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about Sustained-Release Desvenlafaxine Hydrochloride
What is Sustained-Release Desvenlafaxine Hydrochloride?
Sustained-Release Desvenlafaxine Hydrochloride is a Small molecule drug developed by Jiangsu Hansoh Pharmaceutical Co., Ltd..
Who makes Sustained-Release Desvenlafaxine Hydrochloride?
Sustained-Release Desvenlafaxine Hydrochloride is developed by Jiangsu Hansoh Pharmaceutical Co., Ltd. (see full Jiangsu Hansoh Pharmaceutical Co., Ltd. pipeline at /company/jiangsu-hansoh-pharmaceutical-co-ltd).
What development phase is Sustained-Release Desvenlafaxine Hydrochloride in?
Sustained-Release Desvenlafaxine Hydrochloride is in Phase 2.